| Sensitivity of plasma BRAFmutant and NRASmutant cell-free DNA assays to detect metastatic melanoma in patients with low RECIST scores and non-RECIST disease progression GA Chang, JS Tadepalli, Y Shao, Y Zhang, S Weiss, E Robinson, ... Molecular oncology 10 (1), 157-165, 2016 | 76 | 2016 |
| Intrinsic membrane properties of locus coeruleus neurons in Mecp2-null mice X Zhang, N Cui, Z Wu, J Su, JS Tadepalli, S Sekizar, C Jiang American Journal of Physiology-Cell Physiology 298 (3), C635-C646, 2010 | 71 | 2010 |
| Involvement of TRP channels in the CO2 chemosensitivity of locus coeruleus neurons N Cui, X Zhang, JS Tadepalli, L Yu, H Gai, J Petit, RT Pamulapati, X Jin, ... Journal of neurophysiology 105 (6), 2791-2801, 2011 | 44 | 2011 |
| TERT, BRAF, and NRAS mutational heterogeneity between paired primary and metastatic melanoma tumors GA Chang, JM Wiggins, BC Corless, MM Syeda, JS Tadepalli, S Blake, ... Journal of Investigative Dermatology 140 (8), 1609-1618. e7, 2020 | 20 | 2020 |
| Associations between TERT promoter mutations and survival in superficial spreading and nodular melanomas in a large prospective patient cohort GA Chang, E Robinson, JM Wiggins, Y Zhang, JS Tadepalli, CN Schafer, ... Journal of Investigative Dermatology 142 (10), 2733-2743. e9, 2022 | 7 | 2022 |
| Somatic and germline analyses of a long term melanoma survivor with a recurrent brain metastasis S Weiss, F Darvishian, J Tadepalli, R Shapiro, J Golfinos, A Pavlick, ... BMC cancer 15, 1-6, 2015 | 2 | 2015 |
| Analysis of TERT promoter mutations, polymorphisms, clinicopathologic features and recurrence-free survival in primary melanoma. G Chang, EM Robinson, JS Tadepalli, C Salvaggio, Y Zhang, Y Shao, ... Journal of Clinical Oncology 34 (15_suppl), e21065-e21065, 2016 | | 2016 |
| Abstract A31: Association between TERT promoter mutations and BRAF/NRAS mutations in patients with primary and metastatic melanoma tumors GA Chang, JS Tadepalli, NH Fleming, K Lui, Y Shao, F Darvishian, ... Cancer Research 75 (14_Supplement), A31-A31, 2015 | | 2015 |
| Quantitative assessment of circulating BRAF DNA in stage IV melanoma patients undergoing BRAF inhibitor treatment D Polsky, JS Tadepalli, G Chang, N Fleming, Y Shao, AC Pavlick, ... Cancer Research 74 (19_Supplement), 2847-2847, 2014 | | 2014 |
| Droplet digital PCR monitoring of BRAF and NRAS plasma DNA as biomarkers of treatment response in stage IV melanoma. D Polsky, JS Tadepalli, G Chang, NH Fleming, Y Shao, AC Pavlick, ... Journal of Clinical Oncology 32 (15_suppl), 9019-9019, 2014 | | 2014 |
| Analysis of plasma-based BRAF and NRAS mutation detection in patients with stage III and IV melanoma. D Polsky, JS Tadepalli, S Hafner, G Chang, NH Fleming, Y Shao, ... Journal of Clinical Oncology 31 (15_suppl), 9023-9023, 2013 | | 2013 |
| Liquid Biopsy: the Application of Allele-Specific PCR (AS-PCR) and Mutation-Directed SNaPshot Assay to Detect BRAF and NRAS Mutant DNA in Peripheral Blood from Metastatic … JS Tadepalli, S Hafner, J Kristol, CD Galderisi, CS Spittle, EE Bruening, ... JOURNAL OF MOLECULAR DIAGNOSTICS 14 (6), 711-711, 2012 | | 2012 |
| Systematic Studies of Kir and TRP Channel mRNAs in the Norepinephrenergic Neurons of the Locus Coeruleus SJ Tadepalli | | 2011 |
| Analysis of plasma-based BRAF and NRAS mutation detection in patients with stage III and IV melanoma JS Tadepalli, S Hafner, G Chang, NH Fleming, Y Shao, F Darvishian, ... | | |
